| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1997;29:822-827.)
© 1997 American Heart Association, Inc.
Articles |
the Institute of Biomedicine, Department of Pharmacology and Toxicology, University of Helsinki (E.M.A.M., J.L., T.-L.T., K.K., H.V., H.K.); the Division of Transplantation Surgery, Fourth Department of Surgery, Helsinki University Central Hospital (A.-K.P., L.L., J.A.); Mila Ltd (J.L.); and the Department of Physiology, Faculty of Veterinary Medicine, University of Helsinki (T.-L.T.), Finland.
Correspondence to Eero Mervaala, MD, PhD, Institute of Biomedicine, Department of Pharmacology and Toxicology, PO Box 8, FIN-00014 University of Helsinki, Finland. E-mail eero.mervaala@helsinki.fi
Arterial hypertension, nephrotoxicity, and magnesium loss are common side effects of the immunosuppressive agent cyclosporin A (CsA). In the present study, the effects of dietary sodium and magnesium on CsA toxicity were examined in spontaneously hypertensive rats. A 6-week treatment with CsA during a moderately low-sodium diet (Na 0.3%, Mg 0.2% of the dry weight of the chow) raised blood pressure only slightly, without evidence of nephrotoxicity. By contrast, CsA during a high-sodium diet (Na 2.6%) produced a pronounced rise in blood pressure as well as marked nephrotoxicity, comprising decreased creatinine clearance, increased levels of serum creatinine and urea, and increased urinary protein excretion. During the high-sodium diet, CsA decreased myocardial and bone magnesium concentration and increased myocardial and renal calcium concentration. Magnesium supplementation (Mg 0.6%) protected against the CsA-induced hypertension and nephrotoxicity during the high-sodium diet. Magnesium supplementation also completely prevented the CsA-induced myocardial magnesium depletion and calcium accumulation in the heart and kidney during the high-sodium diet. Our findings indicate a detrimental interaction between increased sodium intake and CsA treatment and a marked protection by concomitant oral magnesium supplementation.
Key Words: cyclosporine rats, spontaneously hypertensive hypertrophy, left ventricular proteinuria sodium magnesium calcium
This article has been cited by other articles:
![]() |
R. M. Touyz Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1103 - H1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy Cardiovasc Res, February 1, 2002; 53(2): 294 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Baum Weight Gain and Cardiovascular Risk After Organ Transplantation JPEN J Parenter Enteral Nutr, May 1, 2001; 25(3): 114 - 119. [Abstract] [PDF] |
||||
![]() |
Z. J. Cheng, T. Vaskonen, I. Tikkanen, K. Nurminen, H. Ruskoaho, H. Vapaatalo, D. Muller, J.-K. Park, F. C. Luft, and E. M. A. Mervaala Endothelial Dysfunction and Salt-Sensitive Hypertension in Spontaneously Diabetic Goto-Kakizaki Rats Hypertension, February 1, 2001; 37(2): 433 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mervaala, D. N. Muller, J.-K. Park, R. Dechend, F. Schmidt, A. Fiebeler, M. Bieringer, V. Breu, D. Ganten, H. Haller, et al. Cyclosporin A Protects Against Angiotensin II-Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen Genes Hypertension, January 1, 2000; 35(1): 360 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, R. C. Kowal, F. Rusnak, R. A. Sikkink, E. N. Olson, and R. G. Victor Failure of Calcineurin Inhibitors to Prevent Pressure-Overload Left Ventricular Hypertrophy in Rats Circ. Res., April 2, 1999; 84(6): 722 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Gu, V. Anand, E. W. Shek, M. C. Moore, A. L. Brady, W. C. Kelly, and T. H. Adair Sodium Induces Hypertrophy of Cultured Myocardial Myoblasts and Vascular Smooth Muscle Cells Hypertension, May 1, 1998; 31(5): 1083 - 1087. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |